Anatomic pathology track and trace solutions market projected to grow at a CAGR of 10.4% The anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4% from 2018 to 2023. The increasing volume of diagnostic tests performed in anatomic pathology laboratories and the increasing number of legal cases around cancer misdiagnosis are the key factors driving the growth of the anatomic pathology track and trace solutions market. In addition, the integration of laboratory information systems with track and trace pathology systems and rapid growth in the emerging markets of APAC and Latin America are expected to offer significant growth opportunities for the leading players operating in the anatomic pathology track and trace solutions market. However, the high cost associated with the implementation of track and trace solutions in anatomic pathology laboratories is expected to restrain the growth of this market during the forecast period.
Consumables segment is estimated to witness the highest growth in the anatomic pathology track and trace solutions market, by product, during the forecast period On the basis of product, the anatomic pathology track and trace solutions market is broadly segmented into software, hardware, and consumables. The consumables segment is estimated to grow at the highest CAGR during the forecast period owing to the recurrent use of consumables such as barcode labels & RFID tags (for labeling slides, blocks, and specimens) and the increasing volume of biopsy samples to be tested in laboratories.
RFID segment to witness the highest growth in the anatomic pathology track and trace solutions market, by technology, during the forecast period On the basis of technology, the anatomic pathology track and trace solutions market is segmented into barcode and radiofrequency identification (RFID).The RFID segment is expected to witness the highest growth during the forecast period.
This can be attributed to the increasing adoption of the RFID technology by large-chain pathology laboratories due to advantages such as increased data storage and higher reader throughput (as compared to barcode systems).
Asia Pacific market to witness the highest growth during the forecast period The Asia Pacific region is projected to register the highest growth rate in the anatomic pathology track and trace solutions market during the forecast period. The presence of emerging economies such as China and India; improving standard of living; growing demand for quality medical care; increasing healthcare spending; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for cancer diagnostics are driving the growth of the anatomic pathology track and trace solutions market in the Asia Pacific.
Breakdown of Primary Participants from the Supply Side • By Company Type: Tier 1: 46%, Tier 2: 33%, and Tier 3: 21% • By Designation: C-level: 43%, D-level: 35%, and Others: 22% • By Region: North America: 38%, Europe: 26%, Asia Pacific: 24%, and the Rest of the World: 12%
Breakdown of Primary Participants from the Demand Side • By End User: Hospital Laboratories: 45%, Independent and Reference Laboratories: 30%, and Other End Users: 25% • By Designation: C-level: 43%, D-level: 35%, and Others: 22% • By Region: North America: 38%, Europe: 26%, Asia Pacific: 24%, and the Rest of the World: 12%
Some of the major players in the anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
Research Coverage: This report analyzes the anatomic pathology track and trace solutions market and aims at estimating the size and future growth potential of the market and its segments (by product, technology, application, end user, and region).The report also includes a product portfolio matrix of the anatomic pathology track and trace solutions available in the market.
It also provides a competitive analysis of key market players, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global anatomic pathology track and trace solutions market. The report analyzes this market by product, technology, application, end user, and region. • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global anatomic pathology track and trace solutions market. • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, application, end user, and region. • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global anatomic pathology track and trace solutions market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players operating in the global anatomic pathology track and trace solutions market.
Our reports have been used by over 10K customers, including:
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
646 pages •
By Global Industry Analysts
• May 2021
Global Laparoscopic Devices Market to Reach $15.8 Billion by 2026
Laparoscopy is a form of minimally invasive surgery used in studying organs in pelvic and abdominal area of the body. The introduction of laparoscopic techniques revolutionized the surgical world through a gradual...
Best foot forward: Revenue will likely rise as more healthcare providers stress the importance of preventive care Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and...
Stretch goals: Rising disposable incomes and an aging population will drive revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged 50 and...
Patient history: The industry will likely benefit from new-and-improved service capability advances Abstract Diagnostic & Medical Laboratories in the US Operators in the Diagnostic and Medical Laboratories industry are an integral part of patients’ medical evaluation and treatment. Laboratories are...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.Although melanoma has high survivability, it remains a significant health...
Health Care Provider
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.